DekaBank Deutsche Girozentrale grew its stake in shares of Ameren Co. (NYSE:AEE – Get Rating) by 13.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 37,084 shares of the utilities provider’s stock after acquiring an additional 4,407 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Ameren were worth $3,324,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of AEE. Capital Investment Advisors LLC lifted its position in Ameren by 3.8% during the fourth quarter. Capital Investment Advisors LLC now owns 3,211 shares of the utilities provider’s stock worth $285,000 after purchasing an additional 117 shares during the period. Assetmark Inc. raised its position in shares of Ameren by 4.1% in the 3rd quarter. Assetmark Inc. now owns 3,155 shares of the utilities provider’s stock valued at $254,000 after buying an additional 125 shares in the last quarter. Quent Capital LLC lifted its holdings in shares of Ameren by 14.1% during the 4th quarter. Quent Capital LLC now owns 1,019 shares of the utilities provider’s stock worth $91,000 after acquiring an additional 126 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in shares of Ameren by 0.6% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 23,298 shares of the utilities provider’s stock worth $2,072,000 after acquiring an additional 149 shares in the last quarter. Finally, Whittier Trust Co. boosted its position in shares of Ameren by 7.9% during the 4th quarter. Whittier Trust Co. now owns 2,046 shares of the utilities provider’s stock worth $182,000 after acquiring an additional 150 shares in the last quarter. 78.42% of the stock is owned by institutional investors and hedge funds.
Ameren Trading Up 1.1 %
NYSE AEE opened at $89.29 on Thursday. The firm has a market capitalization of $23.40 billion, a PE ratio of 21.57, a price-to-earnings-growth ratio of 2.96 and a beta of 0.43. The business’s 50-day moving average price is $85.60 and its two-hundred day moving average price is $85.35. The company has a current ratio of 0.79, a quick ratio of 0.59 and a debt-to-equity ratio of 1.29. Ameren Co. has a 12 month low of $73.28 and a 12 month high of $99.20.
Ameren Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, March 31st. Investors of record on Wednesday, March 15th were issued a $0.63 dividend. This is a positive change from Ameren’s previous quarterly dividend of $0.59. The ex-dividend date of this dividend was Tuesday, March 14th. This represents a $2.52 annualized dividend and a yield of 2.82%. Ameren’s payout ratio is presently 60.87%.
Analyst Ratings Changes
Several equities research analysts have weighed in on the company. Bank of America upped their target price on Ameren from $96.00 to $99.00 and gave the stock a “buy” rating in a research note on Tuesday, April 11th. StockNews.com initiated coverage on Ameren in a research note on Thursday, March 16th. They issued a “hold” rating on the stock. Morgan Stanley lowered their target price on Ameren from $89.00 to $84.00 and set an “equal weight” rating for the company in a research note on Tuesday, March 21st. Guggenheim downgraded shares of Ameren from a “buy” rating to a “neutral” rating and raised their price target for the company from $84.00 to $89.00 in a research note on Monday, January 23rd. Finally, Wells Fargo & Company upped their price objective on shares of Ameren from $97.00 to $101.00 and gave the stock an “overweight” rating in a research report on Monday, April 10th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $94.55.
Insider Buying and Selling at Ameren
In other news, EVP Chonda J. Nwamu sold 3,660 shares of Ameren stock in a transaction dated Thursday, March 9th. The stock was sold at an average price of $83.40, for a total value of $305,244.00. Following the completion of the transaction, the executive vice president now directly owns 36,692 shares of the company’s stock, valued at approximately $3,060,112.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, EVP Chonda J. Nwamu sold 3,660 shares of the firm’s stock in a transaction that occurred on Thursday, March 9th. The shares were sold at an average price of $83.40, for a total transaction of $305,244.00. Following the completion of the sale, the executive vice president now owns 36,692 shares of the company’s stock, valued at approximately $3,060,112.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Rafael Flores sold 1,900 shares of the business’s stock in a transaction on Thursday, February 23rd. The shares were sold at an average price of $86.15, for a total transaction of $163,685.00. Following the transaction, the director now owns 14,172 shares in the company, valued at approximately $1,220,917.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 63,509 shares of company stock valued at $5,221,792. 0.42% of the stock is currently owned by insiders.
Ameren Profile
Ameren Corp. is a public utility holding company, which engages in the provision of electric and natural gas services. It operates through the following segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, Ameren Transmission, and Other. The Ameren Transmission segment consists of the aggregated electric transmission businesses of Ameren Illinois and Ameren Transmission Company of Illinois (ATXI).
Featured Articles
- Get a free copy of the StockNews.com research report on Ameren (AEE)
- ASML Reports Massive Growth, Management Points To Sluggish 2023
- Will Analyst Boost Send Lockheed Martin Shares Up, Up and Away?
- Mullen Automotive: Is The Bloom Off The Rose?
- Diversified Abbott Laboratories Could Reverse And Move Higher
- Okta Reversal In Progress While Catalysts Approach
Receive News & Ratings for Ameren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ameren and related companies with MarketBeat.com's FREE daily email newsletter.
